Sito Mobile (SITO): Connecting Retailers and Brands with Consumers
Market Below Important Support for Seventh Week; Time for Defense?
This Week in Emerging Growth: I’m Taking the Alfred Hitchcock Approach to My Concession
Is Canada Heading Toward Recession?
Arena Pharm (ARNA): Transitioning into Drug Developer after Belviq Approval
Equities.com chats with Ohr Pharmaceutical's (OHRP) Irach Taraporewala and discusses their company's product Squalamine and it's treatment of the wet form of age-related macular degeneration.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2016 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).